Medical Properties Trust, Inc. (NYSE:MPW) Stock Rating Upgraded by JMP Securities

Paterniano Del Favero
Agosto 13, 2017

Finally, Alliancebernstein L.P. boosted its stake in Medical Properties Trust by 97.9% in the first quarter. (NYSE:MPW) posted its earnings results on Wednesday. The firm purchased 109,120 shares of the real estate investment trust's stock, valued at approximately $1,404,000. Naples Global Advisors LLC's holdings in Medical Properties Trust were worth $330,000 at the end of the most recent quarter. Institutional investors own 78.48% of the company's stock. Swiss National Bank boosted its position in Medical Properties Trust by 6.2% in the first quarter. 2,993,354 shares of the stock were exchanged. Stratos Wealth Partners LTD. increased its stake in shares of Medical Properties Trust by 13.4% in the first quarter. BlackRock Inc. now owns 40,047,534 shares of the real estate investment trust's stock valued at $516,212,000 after buying an additional 39,461,340 shares during the last quarter. Finally, Teacher Retirement System of Texas increased its stake in shares of Medical Properties Trust by 2.7% in the first quarter. Teacher Retirement System of Texas now owns 25,175 shares of the real estate investment trust's stock valued at $325,000 after buying an additional 665 shares during the period. Thrivent For Lutherans has 0.01% invested in Medical Properties Trust, Inc. 1,676,844 shares of the company traded hands. Goldman Sachs Group Inc. now owns 1,653,360 shares of the real estate investment trust's stock valued at $21,311,000 after buying an additional 332,602 shares during the period.

Another recent and important Medical Properties Trust, Inc. (NYSE:MPW) traded up 0.15% during mid-day trading on Friday, reaching $12.93. Insiders own 1.00% of the company's stock.

02/10/2017 - Medical Properties Trust, Inc. had its " rating reiterated by analysts at Barclays. The stock has a 50 day moving average of $12.92 and a 200-day moving average of $13.05. (NYSE:MPW) updated its FY18 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of $1.42-1.46 for the period, compared to the Thomson Reuters consensus estimate of $1.43. The business had revenue of $156.40 million during the quarter, compared to analyst estimates of $156.91 million. Medical Properties Trust, Inc. The company's revenue was up 15.9% compared to the same quarter previous year. They expect $0.32 earnings per share, 0.00 % or $0.00 from last year's $0.32 per share. The value of the company's investment in Medical Properties Trust, Inc. increased from $4,516,000 to $4,766,000 a change of $250,000 quarter over quarter.

The business also recently declared a quarterly dividend, which was paid on Friday, July 14th. Shareholders of record on Thursday, June 15th were paid a $0.24 dividend. This represents a $0.96 annualized dividend and a dividend yield of 7.42%.

On 8/18/2016 Medical Properties Trust announced a quarterly dividend of $0.23 5.98% with an ex dividend date of 9/13/2016 which will be payable on 10/13/2016. Medical Properties Trust's dividend payout ratio is now 115.66%.

TRADEMARK VIOLATION NOTICE: This article was first reported by Transcript Daily and is the property of of Transcript Daily. If you are reading this story on another publication, it was copied illegally and reposted in violation of worldwide trademark & copyright law. The legal version of this news story can be accessed at https://www.baseball-news-blog.com/2017/08/07/russell-investments-group-ltd-boosts-stake-in-medical-properties-trust-inc-mpw.html.

MPW has been the topic of several research reports. Medical Properties Trust had 22 analyst reports since September 17, 2015 according to SRatingsIntel. The analysts noted that the move was a valuation call. Deutsche Bank AG raised their price objective on shares of Medical Properties Trust from $13.50 to $15.00 and gave the stock a "buy" rating in a research report on Thursday, April 6th. Stifel Nicolaus reaffirmed a "hold" rating and set a $13.00 target price on shares of Medical Properties Trust in a research report on Friday. Two investment analysts have rated the stock with a sell rating, six have given a hold rating and seven have assigned a buy rating to the company's stock. The stock now has a consensus rating of "Hold" and an average target price of $14.20.

In other Medical Properties Trust news, CFO R Steven Hamner sold 85,000 shares of the firm's stock in a transaction dated Wednesday, June 14th.

On 3/28/2017 Edward K. Aldag, Jr., Chairman, sold 301,845 with an average share price of $12.74 per share and the total transaction amounting to $3,845,505.30. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. As of February 24, 2017, the Company's portfolio consisted of 232 properties, including 215 facilities (of the 220 facilities that it owns) were leased to 30 tenants, five were under development, and the remaining assets were in the form of mortgage loans to four operators.

Altre relazioni OverNewsmagazine

Discuti questo articolo

SEGUI I NOSTRI GIORNALE